1st Apr 2005 15:41
Proteome Sciences plc ("the Company") Mr C Pearce, a director, has converted warrants into 642,840 ordinary shares atUS$0.75 per share on 31 March 2005. Following this transaction Mr Pearce nowholds 5,654,951 ordinary shares in the Company, representing 4.31 % of itsissued ordinary share capital as enlarged by the recent share issue.Application will be made for the shares to be admitted to the AlternativeInvestment Market ("AIM") of the London Stock Exchange plc.ENDPROTEOME SCIENCES PLCRelated Shares:
Proteome